Home » Newsletters » BioWorld Science

BioWorld Science

March 10, 2020

View Archived Issues

Keeping stem cells quiescent enables greater ultimate potency

BioPROTACs cut out middleman, and small molecule

Tumor mutational burden correlates with high-MSI patients in CRC

SS18-SSX fusion-specific Ab for the diagnosis of synovial sarcoma

Nanoform and Orion establish drug-development collaboration

Zhuhai United Laboratories patents new JAK1 and/or TYK2 inhibitors

Primary endpoint missed in ELOQUENT-1 study of Empliciti in newly diagnosed multiple myeloma

CROI in the time of COVID-19: Researchers phoning it in at all-virtual 2020 CROI

TRPV4 found expressed in cartilaginous tumors and may be a potential therapeutic target

Kala reports promising topline data from STRIDE 3 study of Eysuvis in dry eye disease

CEL-SCI applies its LEAPS peptide technology to develop immunotherapy against COVID-19

AbbVie partners with global authorities to evaluate HIV drug for treatment of COVID-19

Dare presents data in support of sildenafil cream for female sexual arousal disorder

Encouraging 48-week data from phase III ATLAS-2M study of long-acting HIV regimen

MDM2 and CDK4 predict metastasis in Leydig cell tumors

MediciNova to develop MN-166 for severe pneumonia and ARDS

U.S. researchers present CDK8 or CDK19 inhibitors

Terns discloses new THRB agonists for NASH

Clavius Pharmaceuticals synthesizes new TGFBR1 inhibitors

Atomwise and Bridge Biotherapeutics establish AI-based research collaboration

Santen and Tracon discontinue development of DE-122 for wet AMD following phase IIa results

Acceleron ends development of ACE-083 following phase II results in Charcot-Marie-Tooth disease

Ascletis offers update on Chinese trial of Ganovo and ritonavir for novel coronavirus pneumonia

FDA approves Ofev for chronic fibrosing interstitial lung diseases with a progressive phenotype

IPH-5201 begins first-in-human study in advanced solid tumors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Laigo raises €11.5M seed money for targeted protein degradation
BioWorld Science
Laigo Bio BV has raised €11.5 million (US$13.7 million) in a seed round for the further development of a new approach to inducing targeted protein degradation by...